Emmers, Mitchell https://orcid.org/0009-0002-7478-2423
Welters, Marij J. P. https://orcid.org/0000-0002-9809-8266
Dietz, Michelle V.
Santegoets, Saskia J.
Boekesteijn, Sanne
Stolk, Anouk
Loof, Nikki M.
Dumoulin, Daphne W. https://orcid.org/0000-0001-5578-7902
Geel, Annemarie L.
Steinbusch, Lauri C. https://orcid.org/0009-0005-4975-9848
Valentijn, A. Rob P. M. https://orcid.org/0009-0000-2020-9037
Cohen, Danielle
de Miranda, Noel F. C. C. https://orcid.org/0000-0001-6122-1024
Smit, Egbert F.
Gelderblom, Hans https://orcid.org/0000-0001-9270-8636
van Hall, Thorbald https://orcid.org/0000-0002-9115-558X
Aerts, Joachim G. https://orcid.org/0000-0001-6662-2951
van der Burg, Sjoerd H. https://orcid.org/0000-0002-6556-0354
Funding for this research was provided by:
Oncode Institute; Clinical Proof of Concept grant
Article History
Received: 10 February 2025
Accepted: 16 May 2025
First Online: 28 May 2025
Competing interests
: T.H. and S.H.B. have filed a patent on the TEIPP24 vaccine. None of the other authors have any competing interests.
: This research aligns with the Inclusion & ethical guidelines embraced by Nature Communications.